ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
167 hedge funds and large institutions have $1.01B invested in Acorda Therapeutics in 2016 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 57 increasing their positions, 58 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
33% less call options, than puts
Call options by funds: $14.5M | Put options by funds: $21.5M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
167
Holding in Top 10
1
Calls
$14.5M
Puts
$21.5M
Top Buyers
| 1 | +$21.6M | |
| 2 | +$12.6M | |
| 3 | +$11.4M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$9.62M |
| 5 |
Goldman Sachs
New York
|
+$9.02M |
Top Sellers
| 1 | -$18.1M | |
| 2 | -$11.5M | |
| 3 | -$7.83M | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$7.03M |
| 5 |
Millennium Management
New York
|
-$6.63M |